Rice Steven J. 4
4 · Vir Biotechnology, Inc. · Filed Jun 29, 2021
Insider Transaction Report
Form 4
Rice Steven J.
Chief Administrative Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-06-25−3→ 444,441 totalExercise: $12.76Exp: 2029-12-10→ Common Stock (3 underlying) - Sale
Common Stock
2021-06-25$50.00/sh−3$150→ 20,000 total - Exercise/Conversion
Common Stock
2021-06-25$12.76/sh+3$38→ 20,003 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
- [F2]1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.